In the IC50 maps grouped by anti-cancer Fv (Fig. 4B), the LH-diabodies with anti-EGFR DL11 or 11F8 domains had very high cytotoxicity, with little dependency on the kind of anti-CD3 fragments used. This evidence concerns the gene PLOD1 and cancer.